Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Diarylheptanoid derivatives with α-synuclein aggregation inhibitory activities from the rhizome of Alpinia officinarum.

  • 2026-06
  • Fitoterapia 191
    • Xue-Yi Li
    • Jun-Feng She
    • Qiu-Mei Lv
    • Li Min
    • Shi-Qin Zhang
    • Lei Shi
    • Xiao-Jun Huang
    • Ying Wang
    • Lei Wang
    • Jian-Guo Song
    • Chun-Tao Che
    • Wen-Cai Ye
    • Zhen-Long Wu

Study Design

Methods
Isolation and identification of diarylheptanoid derivatives from Alpinia officinarum; evaluation of α-synuclein aggregation inhibitory activities using native mass spectrometry and fluorescence-based assays.
Seven undescribed diarylheptanoid derivatives, alpinins A - G (1-7), together with nine known ones (8-16), were isolated and identified from the rhizomes of Alpinia officinarum Hance. Architecturally, compounds 1-4 represent four unusual dimeric diarylheptanoids featuring distinct linkage patterns, while compounds 5 and 6 are newly identified adducts consisting of diarylheptanoid motifs with a sesquiterpene and a monoterpene unit, respectively. The structures and absolute configurations of these compounds were elucidated by comprehensive spectroscopic data, DFT-based DP4+ analysis, as well as electronic circular dichroism (ECD) calculations. Additionally, the α-synuclein aggregation inhibitory activities of these isolates were evaluated using native mass spectrometry and fluorescence-based assays. Among them, compounds 7, 10, 12, and 13 exhibited significant inhibitory effects on α-synuclein aggregation and showed potent neuroprotective activities against α-synuclein aggregate-induced cytotoxicity in SH-SY5Y cells.

Research Insights

    Back to top